1. Home
  2. WK vs IOVA Comparison

WK vs IOVA Comparison

Compare WK & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Workiva Inc.

WK

Workiva Inc.

HOLD

Current Price

$87.45

Market Cap

5.1B

Sector

Technology

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.21

Market Cap

968.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WK
IOVA
Founded
2008
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
968.6M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
WK
IOVA
Price
$87.45
$2.21
Analyst Decision
Strong Buy
Buy
Analyst Count
10
12
Target Price
$104.50
$10.36
AVG Volume (30 Days)
597.7K
9.8M
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$845,522,000.00
$250,425,000.00
Revenue This Year
$22.69
$60.94
Revenue Next Year
$15.85
$60.85
P/E Ratio
N/A
N/A
Revenue Growth
19.86
175.62
52 Week Low
$60.50
$1.64
52 Week High
$116.83
$8.56

Technical Indicators

Market Signals
Indicator
WK
IOVA
Relative Strength Index (RSI) 44.08 46.56
Support Level $89.69 $2.18
Resistance Level $93.71 $2.32
Average True Range (ATR) 2.56 0.12
MACD -0.69 -0.01
Stochastic Oscillator 29.15 18.11

Price Performance

Historical Comparison
WK
IOVA

About WK Workiva Inc.

Workiva Inc is a cloud-native platform that simplifies the complexities of reporting and compliance. Workiva platform empowers customers by connecting and transforming data from hundreds of enterprise resource planning (ERP), human capital management (HCM), and customer relationship management (CRM) systems, as well as other third-party cloud and on-premise applications. Customers use the platform to create, review and publish data-linked documents and reports with greater control, consistency, accuracy, and productivity and it is also used for SEC Filings. Company's Geographical region consist of USA, Netherland, UK, and Others. Majority of revenue is from USA.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: